Question 1

Who are the top researchers at Chimerix (United States)?

Accepted Answer

Ranked on the quality score, Scott A. Foster, Wendy Painter and Garrett Nichols lead among researchers whose main affiliation is Chimerix (United States).

Question 2

What are the most cited papers from Chimerix (United States)?

Accepted Answer

The most cited paper from Chimerix (United States) is "Definitions of Cytomegalovirus Infection and Disease in Transplant Patients for Use in Clinical Trials: Table 1." (Per T Ljungman, Michael Boeckh, Hans Hellmuth Hirsch et al., 2016), with 966 citations. Next come "CMX001 to Prevent Cytomegalovirus Disease in Hematopoietic-Cell Transplantation" (374) and "Sofosbuvir with pegylated interferon alfa-2a and ribavirin for treatment-naive patients with hepatitis C genotype-1 infection (ATOMIC): an open-label, randomised, multicentre phase 2 trial" (298).

Question 3

Which research topics does Chimerix (United States) publish most on?

Accepted Answer

By volume in 2022-now: Cancer, Hypoxia, and Metabolism, Glioma Diagnosis and Treatment, CAR-T cell therapy research and Mitochondrial Function and Pathology.

Question 4

Which keywords describe research at Chimerix (United States)?

Accepted Answer

By fractional works in 2022-now, weighted toward what it does more of than the world: Immunotherapy, Tumor Microenvironment, HIF-1, Warburg Effect, Molecular Classification, Glioblastoma, Temozolomide and Cancer Therapy.

Question 5

Which fields of science does Chimerix (United States) work in?

Accepted Answer

In 2022-now, 51% of research at Chimerix (United States) is in Life Sciences, 45% in Health Sciences. Its largest fields are Medicine (45%), Biochemistry, Genetics and Molecular Biology (43%), Immunology and Microbiology (5%). It does 2.4× the world's share of Life Sciences.

Question 6

Is Chimerix (United States)'s research output growing?

Accepted Answer

Output in 2022-2025 was 64% higher than in 2018-2021.